Skip to main content
Veterinary Medicines

Ventimaxx 25 microgram/ml oral solution for horses

Authorised
  • Clenbuterol hydrochloride

Product identification

Medicine name:
Ventimaxx 25 microgram/ml oral solution for horses
Ventimaxx 25 μg/ml πόσιμο διάλυμα για άλογα
Active substance:
  • Clenbuterol hydrochloride
Target species:
  • Horse
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Clenbuterol hydrochloride
    25.00
    microgram(s)/millilitre
    /
    1.00
    Bottle
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Horse
      • Meat and offal
        28
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QR03CC13
Authorisation status:
  • Valid
Authorised in:
  • Cyprus
Package description:
  • Cardboard box containing 1 white HDPE bottle of 360 ml with white PP child-resistent screw cap with a measuring device.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
  • Floris Veterinaire Produkten B.V.
Responsible authority:
  • Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
  • CY00997V
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0425/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Generic of:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 23/09/2025